Updated clarifications relieve ACFs of many requirements that were instituted at the height of the pandemic.

While DOH has yet to issue updated guidance, the CDC has updated guidance that DOH points to in its Feb. 10^th DAL.

Issued in response to changes in the FDA's emergency use authorizations, the FAQs reiterate requirements to conduct two tests, 48 hours apart, when using antigen point-of-care or at-home tests on symptomatic individuals who test negative.

State directs providers to mask consistent with CDC guidance after Feb. 13^th.